Review Special Issues

Older adults: panoramic view on the COVID-19 vaccination

  • In December 2020, COVID-19 vaccination started in many countries, with which the world community hopes to stop the further spread of the current pandemic. More than 90% of sick and deceased patients belong to the category of older adults (65 years and older). This category of the population is most vulnerable to infectious diseases, so vaccination is the most effective preventive strategy, the need for which for older adults is indisputable. Here we briefly summarize information about age-related changes in the immune system and present current data on their impact on the formation of the immune response to vaccination. Older age is accompanied by the process of biological aging accompanied by involution of the immune system with increased susceptibility to infections and a decrease in the effect of immunization. Therefore, in the ongoing mass COVID-19 vaccination, the older adults are a growing public health concern. The authors provide an overview of the various types of COVID-19 vaccines approved for mass immunization of the population by the end of 2020, including older adults, as well as an overview of strategies and platforms to improve the effectiveness of vaccination of this population. In the final part, the authors propose for discussion a system for assessing the safety and monitoring the effectiveness of COVID-19 vaccines for the older adults.

    Citation: Boris G Andryukov, Natalya N Besednova. Older adults: panoramic view on the COVID-19 vaccination[J]. AIMS Public Health, 2021, 8(3): 388-415. doi: 10.3934/publichealth.2021030

    Related Papers:

    [1] Sudip Bhattacharya . Artificial intelligence, human intelligence, and the future of public health. AIMS Public Health, 2022, 9(4): 644-650. doi: 10.3934/publichealth.2022045
    [2] Gabrielle L. Jenkin, Amber L. Pearson, Graham Bentham, Peter Day, Simon Kingham . Neighbourhood Influences on Children’s Weight-related Behaviours and Body Mass Index. AIMS Public Health, 2015, 2(3): 501-515. doi: 10.3934/publichealth.2015.3.501
    [3] Otobo I. Ujah, Chukwuemeka E Ogbu, Russell S. Kirby . “Is a game really a reason for people to die?” Sentiment and thematic analysis of Twitter-based discourse on Indonesia soccer stampede. AIMS Public Health, 2023, 10(4): 739-754. doi: 10.3934/publichealth.2023050
    [4] Ali S. Abed Al Sailawi, Mohammad Reza Kangavari . Utilizing AI for extracting insights on post WHO's COVID-19 vaccination declaration from X (Twitter) social network. AIMS Public Health, 2024, 11(2): 349-378. doi: 10.3934/publichealth.2024018
    [5] Onyekachi Juliet Okpasuo, Ifeanyi Oscar Aguzie, Anunobi Toochukwu Joy, Fabian C Okafor . Risk assessment of waterborne infections in Enugu State, Nigeria: Implications of household water choices, knowledge, and practices. AIMS Public Health, 2020, 7(3): 634-649. doi: 10.3934/publichealth.2020050
    [6] Oluwafolajimi Adetoye Adesanya, Hilda Amauche Igwe . Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study. AIMS Public Health, 2020, 7(4): 804-815. doi: 10.3934/publichealth.2020062
    [7] Ali Moussaoui, El Hadi Zerga . Transmission dynamics of COVID-19 in Algeria: The impact of physical distancing and face masks. AIMS Public Health, 2020, 7(4): 816-827. doi: 10.3934/publichealth.2020063
    [8] PauleMiquelon, AlainLesage, RichardBoyer, StéphaneGuay, PierreBleau, MoniqueSéguin . Mental Health Service Utilization among Students and Staff in 18 Months Following Dawson College Shooting. AIMS Public Health, 2014, 1(2): 84-99. doi: 10.3934/publichealth.2014.2.84
    [9] Panayota Sourtzi, Petros Galanis, Olympia Konstantakopoulou, Olga Siskou, Daphne Kaitelidou . Factors that influence the health status of immigrants living in Greece. AIMS Public Health, 2020, 7(2): 287-300. doi: 10.3934/publichealth.2020024
    [10] Talal Alharazi, Omar AA Bamaga, Nazeh Al-Abd, Jerold C Alcantara . Intestinal parasitic infection: prevalence, knowledge, attitude, and practices among schoolchildren in an urban area of Taiz city, Yemen. AIMS Public Health, 2020, 7(4): 769-777. doi: 10.3934/publichealth.2020059
  • In December 2020, COVID-19 vaccination started in many countries, with which the world community hopes to stop the further spread of the current pandemic. More than 90% of sick and deceased patients belong to the category of older adults (65 years and older). This category of the population is most vulnerable to infectious diseases, so vaccination is the most effective preventive strategy, the need for which for older adults is indisputable. Here we briefly summarize information about age-related changes in the immune system and present current data on their impact on the formation of the immune response to vaccination. Older age is accompanied by the process of biological aging accompanied by involution of the immune system with increased susceptibility to infections and a decrease in the effect of immunization. Therefore, in the ongoing mass COVID-19 vaccination, the older adults are a growing public health concern. The authors provide an overview of the various types of COVID-19 vaccines approved for mass immunization of the population by the end of 2020, including older adults, as well as an overview of strategies and platforms to improve the effectiveness of vaccination of this population. In the final part, the authors propose for discussion a system for assessing the safety and monitoring the effectiveness of COVID-19 vaccines for the older adults.



    Social media platforms such as Twitter using posts called tweets have altered the way people disseminate information [1]. Sharing of information is made possible by the interactions a tweet generates among users. As compared to a regular user, tweets from a small proportion of users called influencers tend to generate the most interactions. These influencers typically have a large online following and may or may not be experts in the issue of discourse [2],[3]. With the help of these influencers, health information may be communicated to a large audience promptly in situations where it is necessary to do so.

    Studies have reported health-related benefits from the use of social media platforms such as Twitter as well as a concern. It has been reported as an excellent place to discover current topics of discourse about vaccines and also to promote vaccination [4]. By using semantic analysis to identify influencers on Twitter, vaccine-hesitant communities can be identified and targeted for inventions. Perhaps as a platform for information dissemination about health, interactions on Twitter can positively influence users by improving their health-seeking behaviors. They can then become aware of the right source of information and seek the right remedy for their health conditions [5],[6].

    However, sometimes, it is unclear which individuals are influencing these interactions. Given the potential that exists for the dissemination of inaccurate health information [7], there is a need to have experts at the forefront of information dissemination on this platform. Cardiovascular health is an area in which interactions that can lead to a positive health-seeking behavior is needed. This need is made obvious by the growing burden of cardiovascular diseases despite the traditional efforts from various stakeholders [8]. As experts, cardiologists can increase awareness, build partnerships and act as advocates of cardiovascular health in their roles as Twitter influencers [9],[10].

    Traditionally cardiologists are considered experts by their years of experience and their research output. This research output can be measured by different matrixes, one of which is the h-index [Hirsch index—productivity in terms of number of publications and impact (number of citations) of the publication] [11]. One would expect that the most influential cardiologists on Twitter also have the highest research output, but this may not be the case. It will also be interesting to see if the most influential Twitter users in the field of cardiology experts are indeed, in this case physicians. The goal of this study therefore, is to assess the top influencers in the field of cardiology who are actively influencing information dissemination on Twitter and to assess if there is any correlation between the Twitter influence and academic influence of the practicing cardiologists.

    On May 01, 2020, similar to the method used in other studies [12],[13], the Right Relevance Application Programming Interface (API) (www.rightrelevance.com, San Francisco, CA, United States) was queried using the search word “cardiology”. The API generated a Twitter topic score for “cardiology”. This score is a measure of how much interactions from other users an influencer earns from a tweet about a topic in the field of cardiology. Subsequently, a rank list of the top 100 cardiology Twitter influencers with their Twitter handles, Twitter names, Twitter profiles, and the number of followers was generated. We excluded handles belonging to organizations as the study's focus was on individual users. Individuals were characterized by sex, duration in years post fellowship training, occupation, area/field of focus for those who were cardiologist physicians, practice setting (academic hospital practice, academic & private hospital practice, non-academic hospital practice, private hospital practice, and both hospital practice & entrepreneurship), and location. These characteristics were identified on their Twitter profiles and web sources such as Doximity (San Francisco, CA, United States), LinkedIn (Sunnyvale, CA, United States), ResearchGate (Berlin, Germany), and practice and institutional websites. The h-index scores of the top cardiologist influencers were obtained using Scopus (Reed Elsevier, London, United Kingdom) on May 07, 2020, and added to the database to represent their academic influence. The median h-index of the influencers that were cardiologists was calculated and a Pearson correlation was performed between the h-indices of the cardiologists and their Twitter topic score to evaluate the relationship. Statistics and graphical representation were performed in Microsoft Excel (Seattle, WA, United States).

    The top 100 most influential individuals in cardiology on Twitter were evaluated (Table 1). Males made up 70 (70%) of the influencers while 30 (30%) were females. Eighty-eight (88%) of the top influencers were cardiologists; 5 (5%) were journalists; 2 (2%) were surgeons (bariatric and cardiothoracic surgeons); 2 (2%) were other physicians (Family medicine physician and a Lipidologist); 2 (2%) consisted of a physician assistant and a senior hospital scientist, and 1 (1%) was a representative for cardiology patients (Figure 1). Eighty-eight (88%) of influencers worked in the United States and 12 (12%) worked outside the United States. In the US, the most common locations in which they worked include Massachusetts 12/88 (13%) and California 11 (13%). Outside the United States, the most common locations included the United Kingdom 4/12 (33%) and Canada 3/12 (25%) (Table 2).

    Table 1.  API generated ranking of the top 100 influential individuals in cardiology on Twitter.
    Rank Twitter handle Twitter name Post-fellowship duration (years) Occupation
    1. cmichaelgibson Michael C. Gibson 27 Interventional cardiologist
    2. erictopol Eric Topol 35 Cardiologist-scientist
    3. drpascalmeier Pascal Meier 20 General cardiologist
    4. drmarthagulati Martha Gulati 19 Preventive cardiologist
    5. drjohnm John Mandrola 25 General cardiologist
    6. heartotxheartmd John P Erwin III 22 General cardiologist
    7. heartbobh Robert Harrington 27 Interventional cardiologist
    8. drsethdb Seth Bilazarian 27 Interventional cardiologist
    9. hmkyale Harlan Krumholz 28 General cardiologist
    10. drsheilasahni Sheila Sahni 3 Interventional cardiologist
    11. cardiobrief Larry Husten N/A Medical journalist
    12. dlbhattmd Deepak L. Bhatt 20 Interventional cardiologist
    13. gina_lundberg Gina Lundberg 26 Preventive cardiologist
    14. mwaltonshirley Melissa Walton-Shirley 29 General cardiologist
    15. erinmichos Erin D. Michos 13 Preventive cardiologist
    16. ajaykirtane Ajay Kirtane 14 Interventional cardiologist
    17. shelleywood2 Shelley Wood N/A Medical journalist
    18. greggwstone Gregg W. Stone 31 Interventional cardiologist
    19. rwyeh Robert W. Yeh 10 General cardiologist
    20. svraomd Sunil V. Rao 16 Interventional cardiologist
    21. drtoniyasingh Toniya Singh 17 General cardiologist
    22. docsavagetju Michael Savage 35 Interventional cardiologist
    23. drlaxmimehta Laxmi Mehta 14 Preventive cardiologist
    24. keaglemd Kim Eagle 34 General cardiologist
    25. minnowwalsh Minnow Walsh 21 Cardiologist non-invasive imaging
    26. drkevincampbell Kevin Campbell 17 Cardiologist-electrophysiology
    27. heartdocsharon Sharon Mulvagh 31 Cardiologist non-invasive imaging
    28. drroxmehran Roxana Mehran 25 Interventional cardiologist
    29. nmhheartdoc Clyde Yancy 31 General cardiologist
    30. willsuh76 William Suh 10 Interventional cardiologist
    31. drjmieres Jennifer Mieres 28 Cardiologist non-invasive imaging
    32. chadialraies Chadi Alraies 4 Interventional cardiologist
    33. samrrazamd Sam Raza 2 Cardiologist non-invasive imaging
    34. venkmurthy Venk Murthy 8 Cardiologist non-invasive imaging
    35. arh_cardio Andrew R. Houghton 14 Cardiologist non-invasive imaging
    36. sharonnehayes Sharonne Hayes 30 Preventive cardiologist
    37. pamelasdouglas Pamela S Douglas 36 Cardiologist non-invasive imaging
    38. cpcannon Christopher Cannon 20 General cardiologist
    39. drlindamd Linda Girgis N/A Family medicine physician
    40. ejsmd Edward J Schloss 23 Cardiologist-electrophysiology
    41. fischman_david David L. Fischman 29 Interventional cardiologist
    42. ankurkalramd Ankur Kalra 3 Interventional cardiologist
    43. doctorwes Westby Fisher 22 Cardiologist-electrophysiology
    44. califf001 Robert M Califf 38 General cardiologist
    45. vietheartpa Viet Le 16 Cardiology-physician assistant
    46. tctmd_yael Yael L. Maxwell N/A Medical journalist
    47. drdave01 David E. Albert 39 Cardiologist-entrepreneur
    48. pooh_velagapudi Poonam Velagapudi 2 Interventional cardiologist
    49. anastasiasmihai Anastasia S Mihailidou N/A Senior hospital scientist
    50. cpgale3 Chris P Gale 6 General cardiologist
    51. majazayeri Ali Jazayeri 0 Cardiology fellow
    52. nihdirector Francis S. Collins 36 General cardiologist-scientist
    53. sethjbaummd Seth J. Baum 30 Interventional cardiologist
    54. drraviele Raviele Antonio 46 Cardiologist-electrophysiology
    55. leftbundle Mintu Turakhia 12 Cardiologist-electrophysiology
    56. lipiddoc James Underberg N/A Lipidologist
    57. richardbogle Richard Bogle 13 Interventional cardiologist
    58. michaeltctmd Michael O'Riordan N/A Medical journalist
    59. jgrapsa Julia Grapsa 7 Cardiologist non-invasive imaging
    60. ethanjweiss Ethan Weiss 17 Preventive cardiologist
    61. neilflochmd Neil Floch N/A Bariatric surgery
    62. davidmaymd David May 32 Interventional cardiologist
    63. herbaronowmd Herb Aronow 17 Interventional cardiologist
    64. drryanpdaly Ryan P. Daly 10 Cardiologist non-invasive imaging
    65. skathire Sek Kathiresan 12 Preventive cardiologist/entrepreneur
    66. cardiacconsult Jordan Safirstein 12 Interventional cardiologist
    67. pnatarajanmd Pradeep Natarajan 5 Preventive cardiologist
    68. debbemccall Debbe McCall N/A Patient research/representative
    69. davidlbrownmd Clinically Conservative Cardiologist 27 Interventional cardiologist
    70. jjheart_doc James Januzzi 20 Cardiologist non-invasive imaging
    71. onco_cardiology Juan Lopez-Mattei 7 Cardio-oncologist
    72. drjohndaymd John Day 20 Cardiologist-electrophysiology
    73. aalahmadmd Amin Al-Ahmad 17 Cardiologist-electrophysiology
    74. toddneale Todd Neale N/A Medical journalist
    75. josejgdnews Jose Juan Gomez 25 Cardiologist non-invasive imaging
    76. jonhsumd Jonathan Hsu 7 Cardiologist-electrophysiology
    77. mkittlesonmd Michelle Kittleson 15 Heart transplant cardiologist
    78. lisarosenbaum17 Lisa Rosenbaum 8 Interventional cardiologist
    79. toaster_pastry Wayne Whitwam 14 Cardiologist-electrophysiology
    80. avolgman Annabelle Volgman 30 Cardiologist-electrophysiology
    81. rblument1 Roger Blumenthal 28 Preventive cardiologist
    82. achoiheart Andrew D. Choi 10 Cardiologist non-invasive imaging
    83. mgkatz036 Michael Katz 5 Cardiologist-electrophysiology
    84. prashsanders Prashanthan Sanders 17 Cardiologist-electrophysiology
    85. bcostellomd Briana Costello 0 Interventional cardiologist
    86. popmajeffrey Jeffrey Popma 30 Interventional cardiologist
    87. adribaran Adrian Baranchuk 23 Cardiologist-electrophysiology
    88. sandylewis Sandra Lewis 37 General cardiologist
    89. yadersandoval Yader Sandoval 3 Interventional cardiologist
    90. drquinncapers4 Quinn Capers 21 Interventional cardiologist
    91. dramirkaki Amir Kaki 11 Interventional cardiologist
    92. jamesbeckerman James Beckerman 14 Genera cardiologist
    93. eirangorodeski Eiran Gorodeski 11 General cardiologist
    94. docstrom Jordan Strom 3 Cardiologist non-invasive imaging
    95. dbelardomd Danielle Belardo 0 Cardiology Fellow
    96. sergiopinski Sergio Pinski 27 Cardiologist-electrophysiology
    97. arieblitzmd Arie Blitz N/A Cardiothoracic surgeon
    98. ash71us Ashish Aneja 8 General cardiologist
    99. tjaredbunch Thomas Jared Bunch 12 Cardiologist-electrophysiology
    100. rfredberg Rita Redberg 32 General cardiologist

     | Show Table
    DownLoad: CSV
    Figure 1.  Percent distribution of the top influencers in the field of cardiology.
    Table 2.  Practice location of the top 100 most influential individuals.
    United States Percentage International Percentage
    Massachusetts 13.64% United Kingdom 33.33%
    California 12.50% Canada 25.00%
    Texas 7.95% Switzerland 8.33%
    New York 7.95% South wales 8.33%
    Ohio 6.82% Italy 8.33%
    New Jersey 4.55% Spain 8.33%
    Connecticut 3.41% Australia 8.33%
    Baltimore 3.41%
    North Carolina 3.41%
    Pennsylvania 3.41%
    Michigan 3.41%
    Illinois 3.41%
    Utah 3.41%
    Kentucky 2.27%
    Missouri 2.27%
    Indiana 2.27%
    Minnesota 2.27%
    Kansas 2.27%
    Florida 2.27%
    Oregon 2.27%
    Arizona 1.14%
    Georgia 1.14%
    Nebraska 1.14%
    Rhode Island 1.14%
    Washington 1.14%
    Wisconsin 1.14%

     | Show Table
    DownLoad: CSV

    Approximately 63/88 (72%) of the top influencers that were cardiologists were males and 25/88 (28%) were females. Of the 88 cardiologists, 87 were actively practicing. Of the practicing cardiologists, about 50/87 (57%) of them worked primarily in an academic hospital setting, 33/87 (38%) in non-academic hospitals, 2/87 (2%) in both academic & private facilities, 1/87 (1%) in private hospitals alone, and 1/87 (1%) worked both in a non-academic hospital and as an entrepreneur. As shown in Figure 2, Twenty-seven (31%) of cardiologist influencers were focused in interventional cardiology, 20/88 (23%) in general cardiology, 15/88 (17%) in electrophysiology, 13/88 (15%) in cardiac non-invasive imaging and 9/88 (10%) in preventive cardiology.

    Figure 2.  Distribution of cardiologist by specialty.

    The median and mean h-index of the top influencers who were cardiologists was 22 (interquartile range = 32.5) and 41.84 ± 9.89 (mean ± 95% CI) respectively. There was a moderately positive correlation between their Twitter topic score and h-index, r = +0.32 (p-value 0.002).

    The study aimed to assess the top individuals driving the discussions in cardiology on Twitter and to analyze if they were as influential in academia as they were on Twitter. We found out that the top 100 Twitter influencers were male cardiologists in the United States with 30% women, they work in academic hospitals and interventional cardiologists represent the largest proportion of cardiologists among the influencers. In addition, there was a moderately positive correlation between their academic and Twitter influence.

    Most of the top 100 cardiology Twitter influencers were US cardiologists. This made up about 85% of the total population studied. They also practice mostly in academic institutions. These individuals are currently influencing the engagements in the field of cardiology on Twitter, and it is consistent with findings from other studies. These other studies evaluated the top influencers in other medical fields on Twitter and found them to be experts in these fields [12],[13]. This is important given that people are more likely to engage a post on Twitter when experts lead the discussion [14]. However, this may not be enough to prevent the dissemination of false information which leads to public mistrust [14],[15], as among the top 100, 12% were non-cardiologists and may be considered as non-experts.

    We also found out that among the influencers that were cardiologists, 2 out of 3 were males. This mostly can be attributed to the small percentage of women who are currently cardiologists [16]. A recent study reported that despite the high percentage of female internal medicine residents, only about 13% of cardiologists are women [17]. Although it is not surprising that females are a minority, with 1 in 3 cardiology influencers being females, it however shows a larger representation of female cardiologists on Twitter which doubles the current trend in the US. There also seems to be a flattening of the hierarchy with a mix of early career (e.g., Briana Costello, Sam Raza), mid-career (e.g., William Suh, Andrew R. Houghton) and advanced stage career (e.g., Michael Gibson, Martha Gulati) professionals being among the top influencers. A positive finding given the criticism the historical hierarchy in medicine has received in recent years [18].

    With regards to their location, only a few cardiologists outside the US were part of the top 100 cardiology influencers. This may be attributed to reports of anti-social media policies in some European countries [19] and the resultant low adoption rates of social media platforms [20],[21]. This may account for why fewer cardiologists outside the US are currently in the top 100 influencers on Twitter. Nevertheless, findings of the massive use of Twitter during European conferences to share impressions have been reported [22],[23]. In addition, Twitter has been reported as a source of data in the research of noncommunicable diseases in European studies [24]. These reports are inconsistent with the reported anti-social media policies outside the US and there may be other reasons behind these findings.

    In addition, we found out that most of the top cardiologist influencers practice in academic hospitals. Studies have shown a high research output from cardiologists who practice in this setting as compared to those who practice in non-academic settings [25]. This is due to the heavy emphasis on research in academic hospitals as compared to non-academic hospitals. These cardiologists have also been found to be more likely to tweet about conferences, research activities, and meetings they attend [26] as compared to those in non-academic settings.

    With regards to the overall academic influence, the median h-index of the top cardiologist influencers (median h-index, 22) found in our study was higher than that of the orthopedic (median h-index, 7) and plastic surgeons (median h-index, 5) in studies done in 2018 and 2019 respectively [12],[13]. In a comparison of the median h-index and their Twitter influence, there was a moderately positive correlation between the two. The moderate positive relationship implies that not only are these top influential cardiologists more active in research as compared to other specialties, they are also almost as influential on Twitter as they are in academia. The most active influential cardiologists may be tweeting more about breakthroughs in cardiovascular research [27]. This is relevant as social media has become a tool to reach millions of people and gather data, and as such, physicians need to be conversant and active in its use. Twitter is a tool to promote and direct attention to specific research topics [28] and was found to be an effective way to increase citations of a publication, influencing the h-index of an author [29].

    This study has a few strengths. First, the large sample size of this study allowed for adequate characterization of the influencers. Second, we used the Right Relevance API which has successfully been used to mine data from Twitter for other studies. Third, the academic influence was computed using the h-index, a scoring system that shows a high correlation with other variants [30]. Despite the strengths of this study, it has some limitations worthy of note. First, the data was made of incomplete Twitter profiles that had to be completed using sources such as Doximity and LinkedIn. Second, a different API using another algorithm may generate a data set entirely different from this data set. Third, there are other social media platforms apart from Twitter where other cardiologists may be more active such as Facebook and Instagram. Lastly, the h-index pays attention only to h-core papers, ignores most papers with a low citation frequency, and lacks sensitivity to highly cited papers.

    In conclusion, our study showed that when examining the influential voices in cardiology on Twitter, there is a broad range of sub-specialties represented, with interventional cardiologists being the most prominent. There was a geographical diversity as well as a flattening of the hierarch, with a mix of early career (e.g., Briana Costello, Sam Raza), mid-career (e.g., William Suh, Andrew R. Houghton) and advanced stage career (e.g., Michael Gibson, Martha Gulati) professionals. Thirty percent were women, which more than doubles the number of women estimated to be practicing cardiovascular medicine. This reflects the challenges that remains in closing the gender gap between men and women as influencers in cardiovascular medicine. These influencers were as influential in the academia as they are on Twitter. Future studies should exam the contents of the posts made by these influencers and also consider other indexes of academic influence like g-index, AR-index, p-index, and integrated impact indicator or academic trace as they relate to social media influence.


    Acknowledgments



    Thank you to the anonymous referees for providing useful comments and suggestions.

    Author contributions



    B.G.A.: idea and writing plan, approval of the final version, collection and analysis of literature, preparation of a draft manuscript; N.N.B.: concept, methodology, approval of the final review. All authors have read and agreed to the published version of the manuscript.

    Conflicts of interest



    The authors declare that they have no conflict of interests.

    [1] United Nations: Department of Economic and Social Affairs, Population Division (2019)  World Population Prospects 2019: Highlights (ST/ESA/SER.A/423) United Nations New York: Available from: https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf.
    [2] United Nations: Department of Economic and Social Affairs Population Dynamics World Population Prospects 2019 Available from: https://population.un.org/wpp/DataQuery/.
    [3] Bektas A, Schurman SH, Sen R, et al. (2017) Human T cell immunosenescence and inflammation in aging. J Leukoc Biol 102: 977-988. doi: 10.1189/jlb.3RI0716-335R
    [4] Austad SN, Hoffman JM (2018) Is antagonistic pleiotropy ubiquitous in aging biology? Evol Med Public Hlth 2018: 287-294. doi: 10.1093/emph/eoy033
    [5] Fülöp T, Larbi A, Witkowski JM (2019) Human Inflammaging. Gerontology 65: 495-504. doi: 10.1159/000497375
    [6] Pinti M, Appay V, Campisi J, et al. (2016) Aging of the immune system: Focus on inflammation and vaccination. Eur J Immunol 46: 2286-2301. doi: 10.1002/eji.201546178
    [7] Oh SJ, Lee JK, Shin OS (2019) Aging and the Immune System: The Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity. Immune Netw 19: e37. doi: 10.4110/in.2019.19.e37
    [8] Crooke SN, Ovsyannikova IG, Poland GA, et al. (2019) Immunosenescence and human vaccine immune responses. Immun Ageing 16: 25. doi: 10.1186/s12979-019-0164-9
    [9] World Health Organization COVID-19 vaccines Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
    [10] Center for Disease Control and Prevention Weekly Updates by Select Demographic and Geographic Characteristics Available from: https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#AgeAndSex.
    [11] Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096. doi: 10.1016/j.vaccine.2007.03.046
    [12] Gralinski LE, Menachery VD (2020) Return of the Coronavirus: 2019-nCoV. Viruses 12: 135. doi: 10.3390/v12020135
    [13] Cianci R, Franza L, Massaro MG, et al. (2020) The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines. Vaccines (Basel) 8: 636. doi: 10.3390/vaccines8040636
    [14] Zhang Y, Zeng G, Pan H, et al. (2020) Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis S1473–3099: 30987.
    [15] Xia S, Zhang Y, Wang Y, et al. (2020) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 21: 39-51. doi: 10.1016/S1473-3099(20)30831-8
    [16] Thompson HL, Smithey MJ, Surh CD, et al. (2020) Functional and Homeostatic Impact of Age-Related Changes in Lymph Node Stroma. Front Immunol 8: 706. doi: 10.3389/fimmu.2017.00706
    [17] Song CY, Xu J, He JQ, et al. (2020) Immune dysfunction following COVID-19, especially in severe patients. Sci Rep 10: 15838. doi: 10.1038/s41598-020-72718-9
    [18] Connors J, Bell MR, Marcy J, et al. (2021) The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience 43: 31-51. doi: 10.1007/s11357-021-00323-3
    [19] Arvey A, Rowe M, Legutki JB, et al. (2020) Age-associated changes in the circulating human antibody repertoire are upregulated in autoimmunity. Immun Ageing 17: 28. doi: 10.1186/s12979-020-00193-x
    [20] Frawley T, van Gelderen F, Somanadhan S, et al. (2020) The impact of COVID-19 on health systems, mental health and the potential for nursing. Ir J Psychol Med 16: 1-7. doi: 10.1017/ipm.2020.105
    [21] Ponnappan S, Ponnappan U (2011) Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal 14: 1551-1585. doi: 10.1089/ars.2010.3228
    [22] Solana R, Pawelec G, Tarazona R (2006) Aging and innate immunity. Immunity 24: 491-494. doi: 10.1016/j.immuni.2006.05.003
    [23] Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15: 505-522. doi: 10.1038/s41569-018-0064-2
    [24] Gubbels Bupp MR, Potluri T, Fink AL, et al. (2018) The Confluence of Sex Hormones and Aging on Immunity. Front Immunol 9: 1269. doi: 10.3389/fimmu.2018.01269
    [25] van Eeden C, Khan L, Osman MS, et al. (2020) Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 21: 6351. doi: 10.3390/ijms21176351
    [26] Przemska-Kosicka A, Childs CE, Maidens C, et al. (2018) Age-Related Changes in the Natural Killer Cell Response to Seasonal Influenza Vaccination Are Not Influenced by a Synbiotic: a Randomised Controlled Trial. Front Immunol 9: 591. doi: 10.3389/fimmu.2018.00591
    [27] Guo H, Kumar P, Moran TM, et al. (2009) The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 87: 579-589. doi: 10.1038/icb.2009.60
    [28] Fulop T, Witkowski JM, Le Page A, et al. (2017) Intracellular signalling pathways: targets to reverse immunosenescence. Clin Exp Immunol 187: 35-43. doi: 10.1111/cei.12836
    [29] Zhou R, To KK, Wong YC, et al. (2020) Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity 53: 864-877. doi: 10.1016/j.immuni.2020.07.026
    [30] Fulop T, Larbi A, Dupuis G, et al. (2018) Immunosenescence and Inflamm-Aging as Two Sides of the Same Coin: Friends or Foes? Front Immunol 8: 1960. doi: 10.3389/fimmu.2017.01960
    [31] Iberg CA, Jones A, Hawiger D (2017) Dendritic Cells As Inducers of Peripheral Tolerance. Trends Immunol 38: 793-804. doi: 10.1016/j.it.2017.07.007
    [32] Ray D, Yung R (2018) Immune senescence, epigenetics and autoimmunity. Clin Immunol 196: 59-63. doi: 10.1016/j.clim.2018.04.002
    [33] Agrawal A, Sridharan A, Prakash S, et al. (2012) Dendritic cells and aging: consequences for autoimmunity. Expert Rev Clin Immunol 8: 73-80. doi: 10.1586/eci.11.77
    [34] Agrawal A, Agrawal S, Gupta S (2017) Role of Dendritic Cells in Inflammation and Loss of Tolerance in the Elderly. Front Immunol 8: 896. doi: 10.3389/fimmu.2017.00896
    [35] Agrawal A, Agrawal S, Gupta S (2018) Role of Dendritic Cells in Aging. Handbook of Immunosenescence Cham: Springer.
    [36] Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. (2020) Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell 181: 1036-1045. doi: 10.1016/j.cell.2020.04.026
    [37] Schröder AK, Rink L (2003) Neutrophil immunity of the elderly. Mech Ageing Dev 124: 419-425. doi: 10.1016/S0047-6374(03)00017-4
    [38] Butcher S, Chahel H, Lord JM (2000) Review article: ageing and the neutrophil: no appetite for killing? Immunology 100: 411-416. doi: 10.1046/j.1365-2567.2000.00079.x
    [39] Naccache PH, Lefebvre JS (2014) A straight neutrophil path to healthy aging? Blood 123: 154-156. doi: 10.1182/blood-2013-11-538256
    [40] Mócsai A (2013) Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 210: 1283-1299. doi: 10.1084/jem.20122220
    [41] Dinauer MC (2014) Disorders of neutrophil function: an overview. Methods Mol Biol 1124: 501-515. doi: 10.1007/978-1-62703-845-4_30
    [42] Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15: 505-522. doi: 10.1038/s41569-018-0064-2
    [43] Aiello A, Farzaneh F, Candore G, et al. (2019) Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention. Front Immunol 10: 2247. doi: 10.3389/fimmu.2019.02247
    [44] Rubtsov AV, Rubtsova K, Fischer A, et al. (2011) Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood 118: 1305-1315. doi: 10.1182/blood-2011-01-331462
    [45] Bektas A, Schurman SH, Sen R, et al. (2017) Human T cell immunosenescence and inflammation in aging. J Leukoc Biol 102: 977-988. doi: 10.1189/jlb.3RI0716-335R
    [46] Tu W, Rao S (2016) Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection. Front Microbiol 7: 2111.
    [47] Gustafson CE, Kim C, Weyand CM, et al. (2020) Influence of immune aging on vaccine responses. J Allergy Clin Immunol 145: 1309-1321. doi: 10.1016/j.jaci.2020.03.017
    [48] Park S, Nahm MH (2011) Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun 79: 314-320. doi: 10.1128/IAI.00768-10
    [49] Zhu FC, Guan XH, Li YH, et al. (2020) Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 396: 479-488. doi: 10.1016/S0140-6736(20)31605-6
    [50] Schenkelberg T (2020) Vaccine-induced protection in aging adults and pandemic response. Biochem Biophys Res Commun S0006-291X(20)32020-9.
    [51] Ruan Q, Yang K, Wang W, et al. (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46: 846-848. doi: 10.1007/s00134-020-05991-x
    [52] McElhaney JE, Coler RN, Baldwin SL (2013) Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev Vaccines 12: 759-766. doi: 10.1586/14760584.2013.811193
    [53] Huff WX, Kwon JH, Henriquez M, et al. (2019) The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology. Int J Mol Sci 20: 2810. doi: 10.3390/ijms20112810
    [54] McElhaney JE, Verschoor CP, Andrew MK, et al. (2020) The immune response to influenza in older humans: beyond immune senescence. Immun Ageing 17: 10. doi: 10.1186/s12979-020-00181-1
    [55] Saletti G, Gerlach T, Jansen JM, et al. (2020) Older adults lack SARS CoV-2 cross-reactive T-lymphocytes directed to human coronaviruses OC43 and NL63. Sci Rep 10: 21447. doi: 10.1038/s41598-020-78506-9
    [56] Ma S, Wang C, Mao X, et al. (2019) B Cell Dysfunction Associated with Aging and Autoimmune Diseases. Front Immunol 10: 318. doi: 10.3389/fimmu.2019.00318
    [57] Cancro MP, Hao Y, Scholz JL, et al. (2009) B cells and aging: molecules and mechanisms. Trends Immunol 30: 313-318. doi: 10.1016/j.it.2009.04.005
    [58] Phalke S, Marrack P (2018) Age (autoimmunity) associated B cells (ABCs) and their relatives. Curr Opin Immunol 55: 75-80. doi: 10.1016/j.coi.2018.09.007
    [59] Bulati M, Caruso C, Colonna-Romano G (2017) From lymphopoiesis to plasma cells differentiation, the age-related modifications of B cell compartment are influenced by “inflamm-ageing”. Ageing Res Rev 36: 125-136. doi: 10.1016/j.arr.2017.04.001
    [60] Du SW, Arkatkar T, Jacobs HM, et al. (2019) Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression. Eur J Immunol 49: 170-178. doi: 10.1002/eji.201847641
    [61] Du SW, Arkatkar T, Al Qureshah F, et al. (2019) Functional Characterization of CD11c+ Age-Associated B Cells as Memory B Cells. J Immunol 203: 2817-2826. doi: 10.4049/jimmunol.1900404
    [62] Karnell JL, Kumar V, Wang J, et al. (2017) Role of CD11c+ T-bet+ B cells in human health and disease. Cell Immunol 321: 40-45. doi: 10.1016/j.cellimm.2017.05.008
    [63] Sachinidis A, Xanthopoulos K, Garyfallos A (2020) Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE). Mediterr J Rheumatol 31: 311-318. doi: 10.31138/mjr.31.3.311
    [64] Hartley GE, Edwards ESJ, Aui PM, et al. (2020) Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Sci Immunol 5: eabf8891. doi: 10.1126/sciimmunol.abf8891
    [65] Cañete PF, Vinuesa CG (2020) COVID-19 Makes B Cells Forget, but T Cells Remember. Cell 183: 13-15. doi: 10.1016/j.cell.2020.09.013
    [66] Sosa-Hernández VA, Torres-Ruíz J, Cervantes-Díaz R, et al. (2020) B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients. Front Immunol 11: 611004. doi: 10.3389/fimmu.2020.611004
    [67] Hao Y, O'Neill P, Naradikian MS, et al. (2011) A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118: 1294-304. doi: 10.1182/blood-2011-01-330530
    [68] Park S, Nahm MH (2011) Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun 79: 314-320. doi: 10.1128/IAI.00768-10
    [69] Smetana J, Chlibek R, Shaw J, et al. (2018) Influenza vaccination in the elderly. Hum Vaccin Immunother 14: 540-549. doi: 10.1080/21645515.2017.1343226
    [70] Kwong JC, Campitelli MA, Gubbay JB, et al. (2013) Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 57: 820-827. doi: 10.1093/cid/cit404
    [71] Bonmarin I, Belchior E, Lévy-Bruhl D (2015) Impact of influenza vaccination on mortality in the French elderly population during the 2000–2009 period. Vaccine 33: 1099-1101. doi: 10.1016/j.vaccine.2015.01.023
    [72] Chiu C (2016) Seasonal influenza vaccines and hurdles to mutual protection. Clin Microbiol Infect 22: S113-S119. doi: 10.1016/j.cmi.2016.03.021
    [73] Koldaş ZL (2017) Yaşlı popülasyonda bağışıklama (aşılama) [Vaccination in the elderly population]. Turk Kardiyol Dern Ars 45: 124-127.
    [74] Derhovanessian E, Pawelec G (2012) Vaccination in the elderly. Microb Biotechnol 5: 226-232. doi: 10.1111/j.1751-7915.2011.00283.x
    [75] World Health Organization The COVID-19 candidate vaccine landscape and tracker Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
    [76] World Health Organization COVID-19 vaccines Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines?.
    [77] Precision vaccinations EpiVacCorona Vaccine Available from: https://www.precisionvaccinations.com/vaccines/epivaccorona-vaccine.
    [78] Novavax Coronavirus Vaccine Candidate Updates Available from: https://www.novavax.com/covid-19-coronavirus-vaccine-candidate-updates.
    [79] Keech C, Albert G, Cho I, et al. (2020) Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med 383: 2320-2332. doi: 10.1056/NEJMoa2026920
    [80] Dai L, Gao GF (2020) Viral targets for vaccines against COVID-19. Nat Rev Immunol 18: 1-10.
    [81] Balakrishnan VS (2020) The arrival of Sputnik V. Lancet Infect Dis 20: 1128. doi: 10.1016/S1473-3099(20)30709-X
    [82] Sputnik V GENERAL INFORMATION Available from: https://sputnikvaccine.com/rus/about-vaccine/.
    [83] Johnson & Johnson Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate Available from: https://www.jnj.com/johnson-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate.
    [84] Knoll MD, Wonodi C (2020) Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet S0140-6736(20)32623-4.
    [85] Tanne JH (2020) Covid-19: Pfizer-BioNTech vaccine is rolled out in US. BMJ 371: m4836. doi: 10.1136/bmj.m4836
    [86] Centers for Disease Control and Prevention (CDC) Moderna COVID-19 Vaccine Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html.
    [87] BioRender COVID-19 Vaccine & Therapeutics Tracker Available from: https://biorender.com/covid-vaccine-tracker.
    [88] Coelingh K, Olajide IR, MacDonald P, et al. (2015) Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Expert Rev Vaccines 14: 1331-1346. doi: 10.1586/14760584.2015.1078732
    [89] Singanayagam A, Zambon M, Lalvani A, et al. (2018) Urgent challenges in implementing live attenuated influenza vaccine. Lancet Infect Dis 18: e25-e32. doi: 10.1016/S1473-3099(17)30360-2
    [90] Chua BY, Sekiya T, Jackson DC (2018) Opinion: Making Inactivated and Subunit-Based Vaccines Work. Viral Immunol 31: 150-158. doi: 10.1089/vim.2017.0146
    [91] Brickley EB, Wright PF (2017) Maximising the impact of inactivated polio vaccines. Lancet Infect Dis 17: 680-681. doi: 10.1016/S1473-3099(17)30236-0
    [92] Tripathi NK, Shrivastava A (2018) Recent Developments in Recombinant Protein-Based Dengue Vaccines. Front Immunol 9: 1919. doi: 10.3389/fimmu.2018.01919
    [93] de Vries RD, Rimmelzwaan GF (2016) Viral vector-based influenza vaccines. Hum Vaccin Immunother 12: 2881-2901. doi: 10.1080/21645515.2016.1210729
    [94] Logunov DY, Dolzhikova IV, Zubkova OV, et al. (2020) Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet 396: 887-897. doi: 10.1016/S0140-6736(20)31866-3
    [95] Humphreys IR, Sebastian S (2018) Novel viral vectors in infectious diseases. Immunology 153: 1-9. doi: 10.1111/imm.12829
    [96] Dalmo RA (2018) DNA vaccines for fish: Review and perspectives on correlates of protection. J Fish Dis 41: 1-9. doi: 10.1111/jfd.12727
    [97] Tanne JH (2020) Covid-19: Pfizer-BioNTech vaccine is rolled out in US. BMJ 371: m4836. doi: 10.1136/bmj.m4836
    [98] Lundstrom K (2020) Self-Amplifying RNA Viruses as RNA Vaccines. Int J Mol Sci 21: 5130. doi: 10.3390/ijms21145130
    [99] Dong Y, Dai T, Wei Y, et al. (2020) A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther 5: 237. doi: 10.1038/s41392-020-00352-y
    [100] Armengaud J, Delaunay-Moisan A, Thuret JY, et al. (2020) The importance of naturally attenuated SARS-CoV-2 in the fight against COVID-19. Environ Microbiol 22: 1997-2000. doi: 10.1111/1462-2920.15039
    [101] Alsulaiman JW, Khasawneh AI, Kheirallah KA (2020) Could “trained immunity” be induced by live attenuated vaccines protect against COVID-19? Review of available evidence. J Infect Dev Ctries 14: 957-962. doi: 10.3855/jidc.12805
    [102] Fidel PL, Noverr MC (2020) Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection? mBio 11: e00907-e00920.
    [103] Roukens AH, Soonawala D, Joosten SA, et al. (2011) Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study. PLoS One 6: e27753. doi: 10.1371/journal.pone.0027753
    [104] Monath TP, Cetron MS, McCarthy K, et al. (2005) Yellow fever 17D vaccine safety and immunogenicity in the elderly. Hum Vaccin 1: 207-214. doi: 10.4161/hv.1.5.2221
    [105] Al-Kassmy J, Pedersen J, Kobinger G (2020) Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand? Viruses 12: 861. doi: 10.3390/v12080861
    [106] Locht C (2020) Vaccines against COVID-19. Anaesth Crit Care Pain Med 39: 703-705. doi: 10.1016/j.accpm.2020.10.006
    [107] Wagner A, Garner-Spitzer E, Jasinska J, et al. (2018) Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules. Sci Rep 8: 9825. doi: 10.1038/s41598-018-28111-8
    [108] Dugan HL, Henry C, Wilson PC (2020) Aging and influenza vaccine-induced immunity. Cell Immunol 348: 103998. doi: 10.1016/j.cellimm.2019.103998
    [109] van den Berg SPH, Wong A, Hendriks M, et al. (2018) Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults. Front Immunol 9: 82. doi: 10.3389/fimmu.2018.00082
    [110] Farina SF, Gao GP, Xiang ZQ, et al. (2001) Replication-defective vector based on a chimpanzee adenovirus. J Virol 75: 11603-11613. doi: 10.1128/JVI.75.23.11603-11613.2001
    [111] Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10: 616-629. doi: 10.1016/j.ymthe.2004.07.013
    [112] Vogels R, Zuijdgeest D, van Rijnsoever R, et al. (2003) Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 77: 8263-8271. doi: 10.1128/JVI.77.15.8263-8271.2003
    [113] Nidetz NF, McGee MC, Tse LV, et al. (2020) Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery. Pharmacol Ther 207: 107453. doi: 10.1016/j.pharmthera.2019.107453
    [114] Hinz T, Kallen K, Britten CM, et al. (2017) The European Regulatory Environment of RNA-Based Vaccines. Methods Mol Biol 1499: 203-222. doi: 10.1007/978-1-4939-6481-9_13
    [115] Plotkin S (2014) History of vaccination. Proc Natl Acad Sci USA 111: 12283-12287. doi: 10.1073/pnas.1400472111
    [116] Dalmo RA (2018) DNA vaccines for fish: Review and perspectives on correlates of protection. J Fish Dis 41: 1-9. doi: 10.1111/jfd.12727
    [117] Tanne JH (2020) Covid-19: Pfizer-BioNTech vaccine is rolled out in US. BMJ 371: m4836. doi: 10.1136/bmj.m4836
    [118] Lundstrom K (2020) Self-Amplifying RNA Viruses as RNA Vaccines. Int J Mol 21: 5130. doi: 10.3390/ijms21145130
    [119] Broderick KE, Humeau LM (2017) Enhanced Delivery of DNA or RNA Vaccines by Electroporation. Methods Mol Biol 1499: 193-200. doi: 10.1007/978-1-4939-6481-9_12
    [120] Zheng Z, Diaz-Arévalo D, Guan H, et al. (2018) Noninvasive vaccination against infectious diseases. Hum Vaccin Immunother 14: 1717-1733. doi: 10.1080/21645515.2018.1461296
    [121] Moderna Moderna's Company History Available from: https://www.modernatx.com/about-us/moderna-facts.
    [122] Soiza RL, Scicluna C, Thomson EC (2021) Efficacy and safety of COVID-19 vaccines in older people. Age Ageing 50: 279-283. doi: 10.1093/ageing/afaa274
    [123] Di Pasquale A, Preiss S, Tavares Da Silva F, et al. (2015) Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel) 3: 320-343. doi: 10.3390/vaccines3020320
    [124] Zepp F (2010) Principles of vaccine design-Lessons from nature. Vaccine 28: C14-C24. doi: 10.1016/j.vaccine.2010.07.020
    [125] Levin Y, Kochba E, Shukarev G, et al. (2016) A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. Vaccine 34: 5262-5272. doi: 10.1016/j.vaccine.2016.09.008
    [126] Del Giudice G, Rappuoli R, Didierlaurent AM (2018) Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Semin Immunol 39: 14-21. doi: 10.1016/j.smim.2018.05.001
    [127] Mascola JR, Fauci AS (2020) Novel vaccine technologies for the 21st century. Nat Rev Immunol 20: 87-88. doi: 10.1038/s41577-019-0243-3
    [128] Tregoning JS, Russell RF, Kinnear E (2018) Adjuvanted influenza vaccines. Hum Vaccin Immunother 14: 550-564. doi: 10.1080/21645515.2017.1415684
    [129] Trucchi C, Paganino C, Orsi A, et al. (2015) Influenza vaccination in the elderly: why are the overall benefits still hotly debated? J Prev Med Hyg 56: E37-E43.
    [130] Bonmarin I, Belchior E, Lévy-Bruhl D (2015) Impact of influenza vaccination on mortality in the French elderly population during the 2000–2009 period. Vaccine 33: 1099-1101. doi: 10.1016/j.vaccine.2015.01.023
    [131] Koldaş ZL (2017) Vaccination in the elderly population. Turk Kardiyol Dern Ars 45: 124-127.
    [132] Rizzo C, Rezza G, Ricciardi W (2018) Strategies in recommending influenza vaccination in Europe and US. Hum Vaccin Immunother 14: 693-698. doi: 10.1080/21645515.2017.1367463
    [133] Triglav TK, Poljak M (2013) Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat 22: 65-70.
    [134] Cano Gutierrez C, Reyes-Ortiz C, Borda MG, et al. (2016) Self-reported vaccination in the elderly: SABE Bogota study, Colombia. Colomb Med (Cali) 47: 25-30. doi: 10.25100/cm.v47i1.2107
    [135] Zeevat F, van der Schans J, Boersma WG, et al. (2019) Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice. Vaccine 37: 6282-6284. doi: 10.1016/j.vaccine.2019.08.051
    [136] Naito T, Yokokawa H, Watanabe A (2018) Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother 24: 496-498. doi: 10.1016/j.jiac.2018.01.004
    [137] Domínguez A, Soldevila N, Toledo D, et al. (2016) Project Pi12/02079 Working Group. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study. Hum Vaccin Immunother 12: 1891-1899.
    [138] Francisco PM, Borim FS, Neri AL (2015) Vaccination against influenza in the elderly: data from FIBRA, Campinas, São Paulo, Brazil. Cien Saude Colet 20: 3775-3786. doi: 10.1590/1413-812320152012.19702014
    [139] Forstner C, Kwetkat A, Schleenvoigt B, et al. (2018) Risikoimpfungen im Alter [Vaccinations in the elderly - who, when and which vaccine to use]. MMW Fortschr Med 160: 52-61. doi: 10.1007/s15006-018-0029-8
    [140] Norton EB (2019) Altered responses to pneumococcal vaccination in an elderly diabetic Japanese vaccine trial: The risk of concurrent vaccination strategies. J Diabetes Complications 33: 189-190. doi: 10.1016/j.jdiacomp.2018.12.007
    [141] Kajikawa N, Kataoka Y, Goto R, et al. (2019) Factors associated with influenza vaccination in Japanese elderly outpatients. Infect Dis Health 24: 212-221. doi: 10.1016/j.idh.2019.07.002
    [142] de Boer PT, Pouwels KB, Cox JM, et al. (2013) Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands. Vaccine 31: 1276-1283. doi: 10.1016/j.vaccine.2012.12.067
    [143] Paccalin M, Weinberger B, Nicolas JF, et al. (2010) The intradermal vaccination route—an attractive opportunity for influenza vaccination in the elderly. Eur Geriatr Med 1: 82-87. doi: 10.1016/j.eurger.2010.03.004
    [144] Wang J, Peng Y, Xu H, et al. (2020) The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech 21: 225. doi: 10.1208/s12249-020-01744-7
    [145] Escobar LE, Molina-Cruz A, Barillas-Mury C (2020) BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci USA 117: 17720-17726. doi: 10.1073/pnas.2008410117
    [146] Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64: 1547-1568. doi: 10.1016/j.addr.2012.04.005
    [147] Zhang L, Wang W, Wang S (2015) Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines 14: 1509-1523. doi: 10.1586/14760584.2015.1081067
    [148] Forster AH, Witham K, Depelsenaire ACI, et al. (2020) Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. PLoS Med 17: e1003024. doi: 10.1371/journal.pmed.1003024
    [149] Rouphael NG, Paine M, Mosley R, et al. (2017) TIV-MNP 2015 Study Group. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet 390: 649-658. doi: 10.1016/S0140-6736(17)30575-5
    [150] Korkmaz E, Balmert SC, Sumpter TL, et al. (2021) Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev 171: 164-186. doi: 10.1016/j.addr.2021.01.022
    [151] Nguyen TT, Oh Y, Kim Y, et al. (2021) Progress in microneedle array patch (MAP) for vaccine delivery. Hum Vaccin Immunother 17: 316-327. doi: 10.1080/21645515.2020.1767997
    [152] Hossain MK, Ahmed T, Bhusal P, et al. (2020) Microneedle Systems for Vaccine Delivery: the story so far. Expert Rev Vaccines 19: 1153-1166. doi: 10.1080/14760584.2020.1874928
    [153] Weinberger B (2020) Vaccines for Older Adults: Current Practices and Future Opportunities. Interdiscip Top Gerontol Geriatr. Basel Karger 43: VI-IX.
    [154] Costa R, Castagna A, Ruotolo G (2021) COVID-19 and cardiovascular problems in elderly patients: Food for thought. Aging Med (Milton) 28: 10.1002/agm2.12149.
    [155] Napoli C, Tritto I, Benincasa G, et al. (2020) Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 57: 236-243. doi: 10.1016/j.amsu.2020.07.054
    [156] O'Neill LAJ, Netea MG (2020) BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol 20: 335-337. doi: 10.1038/s41577-020-0337-y
    [157] European Commission I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly Available from: https://cordis.europa.eu/project/id/634446.
    [158] European Centre for Disease Prevention and Control Generic protocol on enhanced surveillance for invasive pneumococcal disease at the EU/EEA level. Stockholm: ECDC Available from: https://www.ecdc.europa.eu/sites/default/files/documents/SpIDnet_Protocol_enhanced_surveillance-2018.pdf.
    [159] Dirmesropian S, Wood JG, MacIntyre CR, et al. (2016) Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges. Pharmacoeconomics 34: 723-731. doi: 10.1007/s40273-016-0393-0
    [160] Gilbert SC (2012) T-cell-inducing vaccines—what's the future. Immunology 135: 19-26. doi: 10.1111/j.1365-2567.2011.03517.x
    [161] Ewer KJ, Barrett JR, Belij-Rammerstorfer S, et al. (2021) T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 27: 270-278. doi: 10.1038/s41591-020-01194-5
    [162] van Marum RJ (2020) Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol 86: 2014-2016. doi: 10.1111/bcp.14539
  • This article has been cited by:

    1. Jonathan D. Windram, Ashley Neal, Colin J. McMahon, Evolution in Congenital Cardiology Education: The Rise of Digital-Learning Tools, 2022, 27728129, 10.1016/j.cjcpc.2022.12.005
    2. Sean Martin, Brittany Rocque, Juliet Emamaullee, Social Media in Transplantation: An Opportunity for Outreach, Research Promotion, and Enhancing Workforce Diversity, 2022, 106, 0041-1337, 2108, 10.1097/TP.0000000000004143
    3. Maiar Elhariry, Kashish Malhotra, Michelle Solomon, Kashish Goyal, Punith Kempegowda, Top 100 #PCOS influencers: Understanding who, why and how online content for PCOS is influenced, 2022, 13, 1664-2392, 10.3389/fendo.2022.1084047
    4. Maarten Albersen, Eduard Roussel, Re: Nicholas Corsi, David-Dan Nguyen, Mohit Butaney, et al. Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact? Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.09.009, 2022, 24054569, 10.1016/j.euf.2022.10.007
    5. Marcela Araujo de Oliveira Santana, Saira Butt, The Top 100 Twitter Influencers in Infectious Diseases, 2023, 5, 2641-5917, 36, 10.1097/IM9.0000000000000111
    6. Jaroslava Kaňková, Alice Binder, Jörg Matthes, Health-Related Communication of Social Media Influencers: A Scoping Review, 2024, 1041-0236, 1, 10.1080/10410236.2024.2397268
    7. Ayushi Garg, Aalam Sohal, Shivam Kalra, Carol Singh, Ishandeep Singh, Jasneet Grewal, Rohin Kansal, Kashish Malhotra, Ramit Mahajan, Vandana Midha, Arshdeep Singh, Ajit Sood, Ashvind Bawa, Inflammatory Bowel Disease and X (Formerly Twitter) Influencers: Who Are They and What Do They Say?, 2023, 2168-8184, 10.7759/cureus.47536
    8. Krestina L. Amon, Melissa Brunner, Andrew J. Campbell, The Reel Health Care Professionals of Instagram: A Systematic Review, 2024, 27, 2152-2715, 172, 10.1089/cyber.2023.0311
    9. Alexis Miller, Ankita Patro, Madelyn N. Stevens, David Scott Fortune, Alexander Gelbard, David S. Haynes, Michael C. Topf, #OtoTwitter: The Top 75 Twitter Influencers in Otolaryngology and Association With Academic Impact, 2024, 170, 0194-5998, 1676, 10.1002/ohn.721
    10. Conner Howard, Ryan McIntire, J. Michael Anderson, Carter Stewart, Haddon McIntosh, James Cornwell, Kim Barron, The top sports medicine influencers on X (formerly Twitter), 2023, 0264-0414, 1, 10.1080/02640414.2023.2259723
    11. Mikołaj Kamiński, Agata Fogel, Adrianna Dylik, Matylda Kręgielska-Narożna, Paweł Bogdański, Whose tweets about obesity and weight loss gain the most attention: celebrities, political, or medical authorities?, 2024, 0307-0565, 10.1038/s41366-024-01689-y
    12. Jaroslava Kaňková, Alice Binder, Jörg Matthes, Helpful or harmful? Navigating the impact of social media influencers’ health advice: insights from health expert content creators, 2024, 24, 1471-2458, 10.1186/s12889-024-21095-3
    13. Boyu Ma, Jamie Rose, Edwin M. Rojas, Jaime Castro-Núñez, Is oral and maxillofacial surgery lagging behind other specialties on X?, 2025, 29, 1865-1569, 10.1007/s10006-025-01359-x
  • Reader Comments
  • © 2021 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6119) PDF downloads(329) Cited by(14)

Figures and Tables

Figures(2)  /  Tables(3)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog